Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026.
- Largest single sale: $2.4M (10,000 shares) of Johnson & Johnson on Jun 11, 2026. Filing
- Last sale before this period: Jun 12, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Johnson & Johnson (JNJ) | EVP, Chief TO and Risk Officer | Jul 11, 2018 | Jun 12, 2026 |
| Labcorp (LH) | Director | Mar 29, 2021 | Feb 13, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 11, 2026, Johnson & Johnson: sold 10,000 shares for $2.4M, no plan disclosed; 10,000 shares acquired by exercising options. 1 filing: 1
- Feb 15, 2026, Johnson & Johnson: 1,241 shares vested; 635 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Johnson & Johnson: 14,357 shares vested; 6,631 shares withheld by the company for taxes. 1 filing: 1
- Feb 11, 2026, Labcorp: 897 shares vested. 1 filing: 1
- Feb 6, 2026, Johnson & Johnson: 38,945 shares acquired by exercising options; 27,270 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.